AA
BSX icon

Advisory Advocates’s Boston Scientific BSX Stock Holding History

Advisory Advocates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
6,674
-456
-6% -$24.8K 0.24% 138
2026
Q1 		$447K Buy
7,130
+28
+0.4% +$2.24K 0.46% 84
2025
Q4 		$677K Buy
+7,102
New +$696K 0.67% 54

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Advisory Advocates's BSX Position: Q2 2026 in Review

Advisory Advocates reduced its Boston Scientific (BSX) stake by 6.4% in Q2 2026, selling an estimated $24.8K and leaving 6,674 shares worth $285K. The position accounts for 0.24% of the portfolio, ranked #138.

Advisory Advocates first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $677K in Q4 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Advisory Advocates held 6,674 shares of Boston Scientific worth $285K as of Q2 2026.
  • Advisory Advocates sold 456 Boston Scientific shares in Q2 2026, an estimated $24.8K.
  • Boston Scientific made up 0.24% of Advisory Advocates's portfolio in Q2 2026, its #138 holding.
  • Advisory Advocates first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Advisory Advocates's Boston Scientific position peaked at $677K in Q4 2025.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.